Cannabis Nurse Truths

Auteur(s): Dr. Denise Foster
Écouter gratuitement

  • Résumé

  • Cannabis Nurse Truths is the voice of reason in a bureaucracy of nonsense. Dr. Denise Foster, PhD, MSN, RN, CNE is a nationally-recognized expert on the medicinal use of cannabis. She teaches doctors, nurses and other educators in its use in modern medicine. We talk about all things cannabis and highlight the research that continues to indicate that cannabis is medicine. New episodes every Wednesday!
    Copyright 2024 All rights reserved.
    Voir plus Voir moins
Hygiene & Healthy Living Troubles et maladies
Voir plus Voir moins
Épisodes
  • Ep. 49 - Is There Such A Thing As A High Functioning Stoner?

    Ep. 49 - Is There Such A Thing As A High Functioning Stoner?
    Feb 5 2025
    Stoner. Pothead. Loser. Couch potato. These are just a few of the choice names for individuals who choose to use a plant to self-medicate or relax. The stereotypes related to the cannabis enthusiast have been crafted over decades of lies and deceit, and in the public eye, cannabis is promoted as a harmful gateway drug only used by the lowest elements of our society. That stereotype is changing fast, as numerous high-profile individuals, like Elon Musk and Robert F. Kennedy Jr., have come out in support of cannabis legalization and appropriate use. To further the conversation, new evidence is indicating that yes, indeed, there are numerous benefits to using cannabis for health and well-being. And within our own culture, we see it every day as high-functioning stoners operate multi-million dollar businesses, participate in physical activity, and perform their daily adult responsibilities without incident. In this episode of Cannabis Nurse Truths, we consider the high-functioning stoner, a mythical creature that is gaining in population as the US continues to move toward cannabis legalization. EPISODE RESOURCES Anderson, D.M., Fe, H.T., Liang, Y., & Sabia, J.J. (2024). Recreational marijuana laws and teen marijuana use, 1993-2021. JAMA Psychiatry, 81(8), 840–842. https://doi.org/10.1001/jamapsychiatry.2024.0698 Bradford, A.C., Lozano-Rojas, F., Shone, H.B., Bradford, W.D., & Abraham, A.J. (2024). Cannabis laws and utilization of medications for the treatment of mental health disorders. JAMA Network Open, 7(9), e2432021. https://doi.org/10.1001/jamanetworkopen.2024.32021 Brenan, M. (2022, August 5). More in U.S. Say Alcohol Adversely Affects Drinkers, Society. Gallup. https://news.gallup.com/poll/395867/say-alcohol-adversely-affects-drinkers-society.aspx Brown, D. (2025, January 14). Canada's Medical Cannabis Market Remains Steady, Exports Continue to Increase. StratCann. https://stratcann.com/news/canada-medical-cannabis-market-exports-increase/ Caulkins, J. P. (2024). Changes in self-reported cannabis use in the United States from 1979 to 2022. Addiction, 119(9), 1648–1652. https://doi.org/10.1111/add.16519 Cavalli, J. M., Cuttler, C., & Cservenka, A. (2025). A naturalistic examination of the acute effects of high-potency cannabis on emotion regulation among young adults: A Pilot study. Human Psychopharmacology: Clinical and Experimental, 40(1), e2915. https://doi.org/10.1002/hup.2915 Centers for Disease Control and Prevention. (2024, August 6). CDC Data Show Improvements in Youth Mental Health but Need for Safer and More Supportive Schools. https://www.cdc.gov/media/releases/2024/p0806-youth-mental-health.html Choo, E.K., Trent, S.A., Nishijima, D.K., Eichelberger, A., Kazmierczak, S., Ye, Y., Brasel, K.J., Audett, A., & Cherpitel, C.J. (2024). Risk of motor vehicle collision associated with cannabis and alcohol use among patients presenting for emergency care. Accident Analysis & Prevention, 198, 107459. https://doi.org/10.1016/j.aap.2024.107459 Coley, R.L., Carey, N., Kruzik, C., Hawkins, S.S., & Baum, C.F. (2024). Recreational cannabis legalization, retail sales, and adolescent substance use through 2021. JAMA Pediatrics, 178(6), 622–625. https://doi.org/10.1001/jamapediatrics.2024.0555 Colorado Department of Public Health & Environment. (2022, June 15). CDPHE releases latest Healthy Kids Colorado Survey data. https://cdphe.colorado.gov/press-release/cdphe-releases-latest-healthy-kids-colorado-survey-data-0 De La Torre, I.D., Hébert, E.T., Kezbers, K.M., Walters, D., Pope, Z.C., Mao, B., Benson, L., Shi, D., Stanley, N., & Businelle, M.S. (2025). Associations between cannabis use and same-day health and substance use behaviors. Addictive Behaviors, 163, 108239. https://doi.org/10.1016/j.addbeh.2024.108239 English, F., & Whitehill, J.M. (2023). Risk factors for adolescent cannabis use in a state with legal recreational cannabis: The role of parents, siblings, and friends. Clinical Therapeutics, 45(6), 589–598. https://doi.org/10.1016/j.clinthera.2023.04.002 Grimm, B. (2017, April 20). 50 Most Successful Marijuana Enthusiasts You Should Know. Rolling Stone. https://www.rollingstone.com/culture/culture-lists/50-most-successful-marijuana-enthusiasts-you-should-know-114790/zayn-malik-3-112209/ Karmakar, B., Mukherjee, G., & Kar, W. (2024). Using penalized synthetic controls on truncated data: A case study on effect of marijuana legalization on direct payments to physicians by opioid manufacturers. Journal of the American Statistical Association, 1–16. https://doi.org/10.1080/01621459.2024.2406583 Marijuana Policy Project. (2025, January 9). New Data Shows Adult-Use Cannabis Legalization Corresponds with Drops in Teen Use. https://www.mpp.org/news/press/new-data-shows-adult-use-cannabis-legalization-corresponds-with-drops-in-teen-use/ McCarthy, J. (2024, August 10). Fully Half of Americans Have Tried Marijuana. Gallup. https://news.gallup.com/poll/509399/...
    Voir plus Voir moins
    1 h et 19 min
  • Ep. 48 - The Entourage Effect is Still a Theory

    Ep. 48 - The Entourage Effect is Still a Theory
    Jan 29 2025
    In 1998, a group of researchers proposed a hypothesis known as the Entourage Effect, in which a multitude of the compounds found in cannabis can synergistically work together based on the fact that these effects were also seen in the synergism properties associated with our own endocannabinoids. However, after 26 years, this hypothesis has never been supported clinically, meaning that while we have a lot of proposals and a lot of research suggesting interactions, we've never actually applied it to a patient population in a real-life setting. In this episode of Cannabis Nurse Truths, we examine this hypothesis known as the Entourage Effect, because while there is a lot of research suggesting this phenomenon is occurring, meaning that something is happening - we just don't know what it is - critics state that there is not enough evidence to support this in science. Their claim is that it is really just a marketing tool to help promote cannabis products. So which is it - an actual phenomenon that explains why cannabis compounds work together to heal the body, or is it just a gimmick to sell more weed? Bottom line; cannabis contains over 500 compounds that all have beneficial physiological effects, so does it really matter which is true? EPISODE RESOURCES Al-Khazaleh, A.K., Zhou, X., Bhuyan, D.J., Münch, G.W., Al-Dalabeeh, E.A., Jaye, K., & Chang, D. (2024). The neurotherapeutic arsenal in Cannabis sativa: Insights into anti-neuroinflammatory and neuroprotective activity and potential entourage effects. Molecules, 29(2), Article 2. https://doi.org/10.3390/molecules29020410 Ben-Shabat, S., Fride, E., Sheskin, T., Tamiri, T., Rhee, M.-H., Vogel, Z., Bisogno, T., De Petrocellis, L., Di Marzo, V., & Mechoulam, R. (1998). An entourage effect: Inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity. European Journal of Pharmacology, 353(1), 23–31. https://doi.org/10.1016/S0014-2999(98)00392-6 Blasco-Benito, S., Seijo-Vila, M., Caro-Villalobos, M., Tundidor, I., Andradas, C., García-Taboada, E., Wade, J., Smith, S., Guzmán, M., Pérez-Gómez, E., Gordon, M., & Sánchez, C. (2018). Appraising the “entourage effect”: Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer. Biochemical Pharmacology, 157, 285–293. https://doi.org/10.1016/j.bcp.2018.06.025 Boggs, D.L., Nguyen, J.D., Morgenson, D., Taffe, M.A., & Ranganathan, M. (2018). Clinical and preclinical evidence for functional interactions of cannabidiol and Δ9-tetrahydrocannabinol. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 43(1), 142–154. https://doi.org/10.1038/npp.2017.209 Christensen, C., Rose, M., Cornett, C., & Allesø, M. (2023). Decoding the postulated entourage effect of medicinal cannabis: What it is and what it isn’t. Biomedicines, 11(8), 2323. https://doi.org/10.3390/biomedicines11082323 Cogan, P.S. (2020). The “entourage effect” or “hodge-podge hashish”: The questionable rebranding, marketing, and expectations of cannabis polypharmacy. Expert Review of Clinical Pharmacology, 13(8), 835–845. https://doi.org/10.1080/17512433.2020.1721281 Cunha, J.M., Carlini, E.A., Pereira, A.E., Ramos, O.L., Pimentel, C., Gagliardi, R., Sanvito, W.L., Lander, N., & Mechoulam, R. (1980). Chronic administration of cannabidiol to healthy volunteers and epileptic patients. Pharmacology, 21(3), 175–185. https://doi.org/10.1159/000137430 Fowler, C.J. (2003). Plant-derived, synthetic and endogenous cannabinoids as neuroprotective agents non-psychoactive cannabinoids, ‘entourage’ compounds and inhibitors of N-acyl ethanolamine breakdown as therapeutic strategies to avoid psychotropic effects. Brain Research Reviews, 18. https://pubmed.ncbi.nlm.nih.gov/12505646/ Gallily, R., Yekhtin, Z., & Hanuš, L.O. (2015). Overcoming the bell‐shaped dose‐response of cannabidiol by using cannabis extract enriched in cannabidiol. Pharmacology & Pharmacy, 6(02), 75–85. https://doi.org/10.4236/pp.2015.62010 Namdar, D., Anis, O., Poulin, P., & Koltai, H. (2020). Chronological review and rational and future prospects of cannabis-based drug development. Molecules, 25(20), Article 20. https://doi.org/10.3390/molecules25204821 Pamplona, F.A., da Silva, L.R., & Coan, A.C. (2018). Potential clinical benefits of CBD-rich cannabis extracts over purified CBD in treatment-resistant epilepsy: Observational data meta-analysis. Frontiers in Neurology, 9, 759. https://doi.org/10.3389/fneur.2018.00759 Russo, E.B. (2011). Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects: Phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology, 163(7), 1344–1364. https://doi.org/10.1111/j.1476-5381.2011.01238.x Russo, E.B. (2016). Beyond cannabis: Plants and the endocannabinoid system. Trends in Pharmacological Sciences, 37(7), 594–605. https://doi.org/...
    Voir plus Voir moins
    1 h et 19 min
  • Ep. 47 - Cannabis in 2024: A Year In Review

    Ep. 47 - Cannabis in 2024: A Year In Review
    Jan 22 2025
    Welcome back to our Cannabis Nurse Truths podcast! Lee and I took some much-needed time off for the holidaze but we are back to share more truths about cannabis as we move into a new year. 2024 was a crazy year for the cannabis industry, and in the United States, we anticipate more changes as federal, state, and even global perceptions of cannabis shift dramatically. In this episode, we reflect on some of the major events that happened in the cannabis industry that saw both successes and failures for everyone involved in cannabis - both businesses and users. But from my perspective as a cannabis nurse, I recognize the underlying trend across the US - cannabis is being used by so many individuals that it can no longer be denied - cannabis is medicine. Welcome to Cannabis Nurse Truths in 2025! EPISODE RESOURCES Bailey, J.A., Tiberio, S.S., Kerr, D.C.R., Epstein, M., Henry, K.L., & Capaldi, D.M. (2023). Effects of cannabis legalization on adolescent cannabis use across 3 studies. American Journal of Preventive Medicine, 64(3), 361–367. https://doi.org/10.1016/j.amepre.2022.09.019 Ballard, J. (2024, July 17). Marijuana Leads Alcohol For Daily Usage. Alcohol Is Well Ahead For Monthly Usage. YouGov. https://today.yougov.com/health/articles/50106-marijuana-leads-alcohol-daily-usage-alcohol-ahead-monthly-usage Bradford, A.C., Lozano-Rojas, F., Shone, H.B., Bradford, W.D., & Abraham, A.J. (2024). Cannabis laws and utilization of medications for the treatment of mental health disorders. JAMA Network Open, 7(9), e2432021. https://doi.org/10.1001/jamanetworkopen.2024.32021 Business Wire. (2025, January 16). The Two Largest Cannabis Industry Groups Combine Policy Advocacy Efforts To Form Singular, Leading Authority Representing Industry In Washington. https://www.businesswire.com/news/home/20250116788639/en/The-Two-Largest-Cannabis-Industry-Groups-Combine-Policy-Advocacy-Efforts-to-Form-Singular-Leading-Authority-Representing-Industry-in-Washington Carrión, R.E., Auther, A.M., McLaughlin, D., Adelsheim, S., Burton, C.Z., Carter, C.S., Niendam, T., Ragland, J.D., Sale, T.G., Taylor, S.F., Tso, I.F., McFarlane, W.R., & Cornblatt, B.A. (2023). Recreational cannabis use over time in individuals at clinical high risk for psychosis: Lack of associations with symptom, neurocognitive, functioning, and treatment patterns. Psychiatry Research, 328, 115420. https://doi.org/10.1016/j.psychres.2023.115420 Caulkins, J. P. (2024). Changes in self-reported cannabis use in the United States from 1979 to 2022. Addiction, 119(9), 1648–1652. https://doi.org/10.1111/add.16519 Cavendish, V. (2025, January 9). New Data Shows Adult-Use Cannabis Legalization Corresponds with Drops in Teen Use. Marijuana Policy Project. https://www.mpp.org/news/press/new-data-shows-adult-use-cannabis-legalization-corresponds-with-drops-in-teen-use/ Centers for Disease Control and Prevention. (n.d.). Youth Risk Behavior Survey: Data Summary & Trends Report 2013-2023. U.S. Department of Health and Human Services. https://www.cdc.gov/yrbs/dstr/pdf/YRBS-2023-Data-Summary-Trend-Report.pdf Colorado Department of Public Health & Environment. (2022, June 15). CDPHE Releases Latest Healthy Kids Colorado Survey Data. https://cdphe.colorado.gov/press-release/cdphe-releases-latest-healthy-kids-colorado-survey-data-0 Darakjian, L., Glassman, H., Lo, C.Y., & Russo, F. (2024). Exploring the interaction between cannabis, hearing, and music. OSF. https://doi.org/10.31234/osf.io/pmuhx Evoy, R., & Victoroff, T. (2024). Prevalence of cannabis use among US workers in 15 states, 2016–2020. American Journal of Public Health, 114(S8), S645–S653. https://doi.org/10.2105/AJPH.2024.307788 Halman, A., Chenhall, R., & Perkins, D. (2024). Changes in pain and mental health symptoms associated with prescribed medicinal cannabis use: A one-year longitudinal study. Journal of Pain & Palliative Care Pharmacotherapy, 1–13. https://doi.org/10.1080/15360288.2024.2414898 Herrington, A.J. (2025, January 13). DEA Judge Cancels Marijuana Rescheduling Hearing Set For Next Week. Forbes. https://www.forbes.com/sites/ajherrington/2025/01/13/dea-judge-cancels-marijuana-rescheduling-hearing-set-for-next-week/ Jaeger, K. (2025, January 8). New York Marijuana Consumption Lounges Could Sell Food And Drinks While Hosting Live Concerts Under New Bill. Marijuana Moment. https://www.marijuanamoment.net/new-york-marijuana-consumption-lounges-could-sell-food-and-drinks-while-hosting-live-concerts-under-new-bill/ Karmakar, B., Mukherjee, G., & Kar, W. (2024). Using penalized synthetic controls on truncated data: A case study on effect of marijuana legalization on direct payments to physicians by opioid manufacturers. Journal of the American Statistical Association, 0(0), 1–16. https://doi.org/10.1080/01621459.2024.2406583 Leatherdale, S.T., Amores, A., Bélanger, R.E., Battista, K., Patte, K.A., & Jiang, Y. (2023). Youth perception of difficulty accessing cannabis following cannabis ...
    Voir plus Voir moins
    1 h et 19 min

Ce que les auditeurs disent de Cannabis Nurse Truths

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.

Évaluations sur Audible.ca

Évaluations sur Amazon.ca
Il n'y a pas encore de critiques pour ce titre.